Publication
Oligomerization Profile of Human Transthyretin Variants with Distinct Amyloidogenicity
Related publications (58)
Hierarchical Protofilament Intertwining Rules the Formation of Mixed-Curvature Amyloid Polymorphs
Giovanni Dietler, Henning Paul-Julius Stahlberg, Meltem Tatli, Francesco Simone Ruggeri, Jiangtao Zhou, Salvatore Assenza, Raffaele Mezzenga
Amyloid polymorphism is a hallmark of almost all amyloid species, yet the mechanisms underlying the formation of amyloid polymorphs and their complex architectures remain elusive. Commonly, two main mesoscopic topologies are found in amyloid polymorphs cha ...
Wiley2024Molecular dissection of amyloid disaggregation by human HSP70
Paolo De Los Rios, Alessandro Barducci
The molecular steps that lead to the disaggregation of amyloid fibrils are shown to involve the synergistic action of HSP70 and its co-chaperones DNAJB1 and HSP110. The deposition of highly ordered fibrillar-type aggregates into inclusion bodies is a hallm ...
NATURE RESEARCH2020Effects of sedimentation, microgravity, hydrodynamic mixing and air-water interface on alpha-synuclein amyloid formation
Giovanni Dietler, Giovanni Longo, Francesco Simone Ruggeri, Jiangtao Zhou
The formation of amyloid fibrils is a characterizing feature of a range of protein misfolding diseases, including Parkinson's disease. The propensity of native proteins to form such amyloid fibril, both in vitro and in vivo, is highly sensitive to the surr ...
ROYAL SOC CHEMISTRY2020Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis
Andrea Cavalli, Alessio Mylonas, Martin Meyer
Systemic amyloidosis is a heterogeneous group of diseases associated with protein misfolding into insoluble beta-sheet rich structures that deposit extracellularly in different organs, eventually compromising their function. There are more than 30 differen ...
E M H SWISS MEDICAL PUBLISHERS LTD2020Half a century of amyloids: past, present and future
Hilal Lashuel, Raffaele Mezzenga
Amyloid diseases are global epidemics with profound health, social and economic implications and yet remain without a cure. This dire situation calls for research into the origin and pathological manifestations of amyloidosis to stimulate continued develop ...
2020Methods of treating amyloid-beta peptide diseases
Johan Auwerx, Laurent Mouchiroud, Vincenzo Sorrentino
The present invention is directed to a method of treating an amyloid-3 peptide disease in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a compound that enhances mitochondrial proteostasi ...
2018